The safety and efficacy of Mounjaro have not been established in pediatric patients. Currently, Mounjaro is not approved for use in patients younger than 18 years. Clinical trials are ongoing to evaluate its use in patients aged 10 to below 18 years with type 2 diabetes.
4 INSTALLMENTS, 6 WEEKS, 0% INTEREST
PharmaServe now offers you the option to make 4-interest-free payments by credit card once your order is confirmed using